Pankaj Bhargava is the founder of Ä_x0081_shibio. Ä_x0081_shibio has raised $40M in total funding. Latest round: Series A.
Pankaj Bhargava, M.D. is the founder and CEO of āshibio. The biotechnology company, founded in 2022, is developing novel therapeutics for bone and connective tissue disorders. The company exited stealth in June 2024 with $40 million in seed and Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library